Case Study : A case study involving a breast cancer patient treated with GcMAF, SDT, and hormone therapy demonstrated that GcMAF and SDT could be used in combination with conventional therapies, especially in cases where treatment options are limited due to toxicity.These studies suggest that GcMAF-based immunotherapy, especially when combined with other treatments, might offer a new approach to cancer treatment. 

These potential benefits highlight the promise of GcMAF in the treatment of breast cancer